Advertisement
Advertisement
U.S. Markets open in 3 hrs 52 mins
Advertisement
Advertisement
Advertisement
Advertisement

Cardiol Therapeutics Inc. (CRDL.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.5300-0.0500 (-1.94%)
At close: 04:00PM EST
Advertisement
Full screen
Loading interactive chart...
  • Newsfile

    Cardiol Therapeutics Announces Closing of US$50 Million Public Offering

    Oakville, Ontario--(Newsfile Corp. - November 5, 2021) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing anti-inflammatory therapies for the treatment of cardiovascular disease, announced today the closing of its previously announced public offering (the "Offering") of 16,350,000 units of the Company (the "Units") at a price to the public of US$3.07 per Unit for gross proceeds of US$50,194,500, before

  • Simply Wall St.

    What You Need To Know About Cardiol Therapeutics Inc.'s (TSE:CRDL) Investor Composition

    The big shareholder groups in Cardiol Therapeutics Inc. ( TSE:CRDL ) have power over the company. Large companies...

  • CNW Group

    Cardiol Therapeutics Announces Pricing of Public Offering of Units

    Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing anti-inflammatory therapies for the treatment of cardiovascular disease (CVD), announced today the pricing of its previously announced public offering (the "Offering") of 16,350,000 units of the Company (the "Units") at a price to the public of US$3.07 per Unit for gross proceeds of US$50,194,500, before deducting the underwriting discounts and commissio

Advertisement
Advertisement